Truvestments Capital’s Array Biopharma Inc ARRY Stock Holding History

Truvestments Capital’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-214	Closed	-$10K	–	751
2019 Q2	$10K	Sell	214 -323	-60%	-$9.07K	0.01%	538
2019 Q1	$13K	Buy	+537	New	+$11.2K	0.01%	485
2018 Q3	$8K	Buy	+548	New	+$8.4K	﹤0.01%	692

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Truvestments Capital's ARRY Position: Q3 2019 in Review

Truvestments Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 214 shares — an estimated $10K sold.

Truvestments Capital first reported a position in ARRY in Q3 2018 and held it in 3 quarters. The position peaked at $13K in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Truvestments Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Truvestments Capital sold 214 Array Biopharma Inc shares in Q3 2019, an estimated $10K.
Truvestments Capital first reported a position in Array Biopharma Inc in Q3 2018 and held it in 3 quarters.
Truvestments Capital's Array Biopharma Inc position peaked at $13K in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Truvestments Capital's 13F filing for Q3 2019, filed 10 Oct 2019.